< Back to previous page
Researcher
Peter Bossuyt
- Disciplines:Endocrinology and metabolic diseases, Gastro-enterology and hepatology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Jun 2015 → Today
Publications
1 - 10 of 155
- Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study](2024)
Authors: Peter Bossuyt
- Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study(2024)
Authors: Dahham Alsoud, João Guedelha Sabino, Peter Bossuyt, Séverine Vermeire, Marc Ferrante
- Baseline Data and Measurement Instruments Reported in Observational Studies in Inflammatory Bowel Disease: Results from a Systematic Review(2024)
Authors: Peter Bossuyt
- Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study(2023)
Authors: Bram Verstockt, Peter Bossuyt
Pages: 1791 - 1799 - Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes(2023)
Authors: Séverine Vermeire, Marc Ferrante, Peter Bossuyt, Gert De Hertogh
- Effect of 104 Weeks of Mirikizumab Treatment on Inflammatory Bowel Disease Questionnaire Scores Among Patients With Moderately to Severely Active Crohn's Disease(2023)
Authors: Peter Bossuyt
Pages: S809 - S809 - Mirikizumab Sustained Improvement on Fatigue in Patients With Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study at Week 104(2023)
Authors: Peter Bossuyt
Pages: S816 - S816 - Long-term follow-up of the red density pilot trial: a basis for long-term prediction of sustained clinical remission in ulcerative colitis?(2023)
Authors: Pieter Sinonquel, Peter Bossuyt, João Guedelha Sabino, Bram Verstockt, Séverine Vermeire, Raf Bisschops
Pages: E880 - E884 - Patient-reported Outcomes and Disability Are Associated with Histological Disease Activity in Patients with Ulcerative Colitis: Results from the APOLLO Study(2023)
Authors: Bram Verstockt, Peter Bossuyt
Pages: 1046 - 1054 - ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease(2023)
Authors: Peter Bossuyt
Pages: 1031 - 1045